Holler E - Search Results

1

Hematopoietic cell transplantation from related and unrelated donors after minimal conditioning as a curative treatment modality for severe paroxysmal nocturnal hemoglobinuria.

Hegenbart U, Niederwieser D, Forman S, Holler E, Leiblein S, Johnston L, Pönisch W, Epner E, Witherspoon R, Blume K, Storb R. Hegenbart U, et al. Among authors: holler e. Biol Blood Marrow Transplant. 2003 Nov;9(11):689-97. doi: 10.1016/s1083-8791(03)00264-7. Biol Blood Marrow Transplant. 2003. PMID: 14652852 Free article.

2

OKT3 muromonab as second-line and subsequent treatment in recipients of stem cell allografts with steroid-resistant acute graft-versus-host disease.

Knop S, Hebart H, Gscheidle H, Holler E, Kolb HJ, Niederwieser D, Einsele H. Knop S, et al. Among authors: holler e. Bone Marrow Transplant. 2005 Nov;36(9):831-7. doi: 10.1038/sj.bmt.1705132. Bone Marrow Transplant. 2005. PMID: 16151429

3

Allogeneic hematopoietic cell transplantation as curative therapy for non-transformed follicular lymphomas.

Heinzelmann F, Bethge W, Beelen DW, Engelhard M, Kröger N, Dreger P, Niederwieser D, Finke J, Bunjes D, Tischer J, Kobbe G, Holler E, Bornhäuser M, Stelljes M, Baurmann H, Müller A, Haubitz I, Schrezenmeier H, Müller C, Ottinger H. Heinzelmann F, et al. Among authors: holler e. Bone Marrow Transplant. 2016 May;51(5):654-62. doi: 10.1038/bmt.2015.348. Epub 2016 Feb 8. Bone Marrow Transplant. 2016. PMID: 26855152

4

Prophylaxis and treatment of GVHD: EBMT-ELN working group recommendations for a standardized practice.

Ruutu T, Gratwohl A, de Witte T, Afanasyev B, Apperley J, Bacigalupo A, Dazzi F, Dreger P, Duarte R, Finke J, Garderet L, Greinix H, Holler E, Kröger N, Lawitschka A, Mohty M, Nagler A, Passweg J, Ringdén O, Socié G, Sierra J, Sureda A, Wiktor-Jedrzejczak W, Madrigal A, Niederwieser D. Ruutu T, et al. Among authors: holler e. Bone Marrow Transplant. 2014 Feb;49(2):168-73. doi: 10.1038/bmt.2013.107. Epub 2013 Jul 29. Bone Marrow Transplant. 2014. PMID: 23892326

5

Use of intrathecal prophylaxis in allogeneic haematopoietic stem cell transplantation for malignant blood diseases: a survey of the European Group for Blood and Marrow Transplantation (EBMT).

Ruutu T, Corradini P, Gratwohl A, Holler E, Apperley J, Dini G, Rocha V, Schmitz N, Socié G, Niederwieser D. Ruutu T, et al. Among authors: holler e. Bone Marrow Transplant. 2005 Jan;35(2):121-4. doi: 10.1038/sj.bmt.1704727. Bone Marrow Transplant. 2005. PMID: 15543201

6

Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients.

Kolb HJ, Schattenberg A, Goldman JM, Hertenstein B, Jacobsen N, Arcese W, Ljungman P, Ferrant A, Verdonck L, Niederwieser D, van Rhee F, Mittermueller J, de Witte T, Holler E, Ansari H; European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia. Kolb HJ, et al. Among authors: holler e. Blood. 1995 Sep 1;86(5):2041-50. Blood. 1995. PMID: 7655033 Free article.

7

Studies on the mechanism of tolerance or graft-versus-host disease in allogeneic bone marrow recipients at the level of cytotoxic T-cell precursor frequencies.

Irschick EU, Hladik F, Niederwieser D, Nussbaumer W, Holler E, Kaminski E, Huber C. Irschick EU, et al. Among authors: holler e. Blood. 1992 Mar 15;79(6):1622-8. Blood. 1992. PMID: 1547351 Free article.

8

Rapid achievement of complete donor chimerism and low regimen-related toxicity after reduced conditioning with fludarabine, carmustine, melphalan and allogeneic transplantation.

Wäsch R, Reisser S, Hahn J, Bertz H, Engelhardt M, Kunzmann R, Veelken H, Holler E, Finke J. Wäsch R, et al. Among authors: holler e. Bone Marrow Transplant. 2000 Aug;26(3):243-50. doi: 10.1038/sj.bmt.1702512. Bone Marrow Transplant. 2000. PMID: 10967561 Clinical Trial.

9

Bleeding events and mortality in SCT patients: a retrospective study of hematopoietic SCT patients with organ dysfunctions due to severe sepsis or GVHD.

Holler E, Kolb HJ, Greinix H, Perrotin D, Campilho F, Aversa F, Gil L, Cornelissen J, Varanese L, Schacht A, Friese A, Rustige J. Holler E, et al. Bone Marrow Transplant. 2009 Mar;43(6):491-7. doi: 10.1038/bmt.2008.337. Epub 2008 Dec 15. Bone Marrow Transplant. 2009. PMID: 19079317

10

Low-dose ARAC, donor cells, and GM-CSF for treatment of recurrent acute myeloid leukemia after allogeneic stem cell transplantation.

Schmid C, Schleuning M, Aschan J, Ringdén O, Hahn J, Holler E, Hegenbart U, Niederwieser D, Dugas M, Ledderose G, Kolb HJ. Schmid C, et al. Among authors: holler e. Leukemia. 2004 Aug;18(8):1430-3. doi: 10.1038/sj.leu.2403412. Leukemia. 2004. PMID: 15201854 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

608 results

Search Page